AngioDynamics, Inc. Business Combination, Contingent Consideration, Liability
AngioDynamics, Inc. (ANGO) had Business Combination, Contingent Consideration, Liability of $27.29 million as of 2020-02-29, per its 10-Q filed 2020-04-08.
Discontinued › Balance Sheet › Liabilities
us-gaap:BusinessCombinationContingentConsiderationLiability · last filed 2020-04-08
- 2020-02-29: Business Combination, Contingent Consideration, Liability $27.29M.
- 2019-11-30: Business Combination, Contingent Consideration, Liability $26.88M.
- 2019-08-31: Business Combination, Contingent Consideration, Liability $11.83M.
- 2019-05-31: Business Combination, Contingent Consideration, Liability $13.49M.
| Period end | Business Combination, Contingent Consideration, Liability |
|---|---|
| 2020-02-29 | $27.29M 10-Q · filed 2020-04-08 |
| 2019-11-30 | $26.88M 10-Q · filed 2020-01-08 |
| 2019-08-31 | $11.83M 10-Q · filed 2019-10-04 |
| 2019-05-31 | $13.49M 10-Q · filed 2020-04-08 |
| 2019-02-28 | $27.13M 10-Q · filed 2019-04-02 |
| 2018-11-30 | $26.52M 10-Q · filed 2019-01-07 |
| 2018-08-31 | $3.97M 10-Q · filed 2018-10-01 |
| 2018-05-31 | $3.26M 10-Q · filed 2019-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |